Arca Biopharma sell StockNews.com
Start price
22.12.23
/
50%
€1.51
Target price
22.12.24
-
Performance (%)
116.61%
Price
25.04.24
€3.26
Summary
This prediction is currently active. The SELL prediction by StockNews_com for Arca Biopharma is trending in the completely wrong direction and now has a performance of 116.61%. This prediction currently runs until 22.12.24. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | - | - |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat